![Eleanor de Groot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eleanor de Groot
Directeur Technique/Scientifique/R&D chez
BRII BIOSCIENCES LIMITED
Profil
Eleanor M.
de Groot is currently the Chief Technology Officer at Brii Biosciences Ltd. (China).
Prior to this, she was the Executive Vice President-Operations at Alaunos Therapeutics, Inc. from 2015 to 2022 and the Vice President-Technical Operations at Helsinn Therapeutics (U.S.), Inc. from 2009 to 2015.
She also held positions as Principal at Guilford Pharmaceuticals, Inc. and Shell Chemicals Ltd., and as Vice President-Technical Operations at Sapphire Therapeutics, Inc. Dr. de Groot holds a doctorate degree from Stanford University, a graduate degree from Stanford University, an MBA from Rice University, and an undergraduate degree from Massachusetts Institute of Technology.
Postes actifs de Eleanor de Groot
| Sociétés | Poste | Début |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Directeur Technique/Scientifique/R&D | 15/08/2022 |
Anciens postes connus de Eleanor de Groot
| Sociétés | Poste | Fin |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Directeur des opérations | 01/05/2022 |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer | Corporate Officer/Principal | 01/07/2015 |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Corporate Officer/Principal | - |
Shell Chemicals Ltd.
 Shell Chemicals Ltd. Chemicals: SpecialtyProcess Industries Manufactures basic inorganic and organic chemicals | Corporate Officer/Principal | - |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Directeur Technique/Scientifique/R&D | - |
Formation de Eleanor de Groot
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
Sapphire Therapeutics, Inc.
Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shell Chemicals Ltd.
Shell Chemicals Ltd. Chemicals: SpecialtyProcess Industries Manufactures basic inorganic and organic chemicals | Process Industries |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer | Health Technology |
Brii Biosciences Ltd. (China)
 Brii Biosciences Ltd. (China) BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Choisissez Zonebourse 
